Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Did a heart attack occur within one year of taking Premphase or Prempro?

Were any of the following problems experienced during or after taking HRT medication?

If you suffered any of the above conditions, what was your age when diagnosed?

What was the date you were diagnosed with TTP?

Please describe diagnosis:

Please describe history of HRT drug prescriptions (please provide date and drug used in chronological order):

If diagnosed with breast cancer, please indicate details of diagnosis:

Have any family members (sisters, mother, grandmothers) been diagnosed with breast cancer?

If yes, please describe which family member was diagnosed and the type of cancer that was diagnosed:

Have you been genetically screened for breast cancer?

If you have been screened for breast cancer, please describe results:

Please describe history of blood clots and/or strokes:

Did you ever take Provera?

If yes, did you take Provera while taking Premphase or Premarin?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Alabama Breast Cancer Victim Awarded $9.45 Million in Prempro Lawsuit

Feb 23, 2010 | Parker Waichman LLP

Pfizer Inc.'s Wyeth unit lost another Prempro lawsuit in Philadelphia yesterday, and has been ordered to pay $9.45 million to an Alabama woman who blamed the hormone drug for her breast cancer.

According to The National Law Journal, this case is the first in the country involving a plaintiff diagnosed with breast cancer well after the July 2002 release of the Women’s Health Initiative (WHI) a major study conducted by the National Institutes of Health (NIH).  The study linked Prempro and similar drugs significantly increased the risk of stroke, blood clots, heart attacks and breast cancer.

According to her lawsuit, Audrey Singleton began taking Prempro in 1997, and stopped taking it in 2004 when she was diagnosed with breast cancer. Singleton was prescribed Prempro during a period in which the label had changed following release the WHI. A plaintiffs’ attorney told the National Law Journal the jury verdict showed the jury found that Wyeth didn’t react appropriately to the WHI.

According to the Philadelphia Inquirer, Singleton, a retired school-bus driver and mother of three, was awarded $3.25 million in compensatory damages and $6 million in punitive damages. The verdict also included $200,000 to Singleton’s husband for loss of consortium.

About 8,000 people who used Wyeth’s hormone-replacement drugs have filed similar suit against the company. Roughly 1,500 such lawsuits are pending in Philadelphia Common Pleas Court.

This is just the latest victory for plaintiffs involved in hormone therapy breast cancer lawsuits. In November, we reported that Wyeth had been ordered to pay punitive damages totaling $103 million in two lawsuits involving Prempro. In the first case, a Philadelphia jury awarded $28 million in punitive damages to a 66-year-old woman who claimed her breast cancer was the result of taking Prempro and Provera. The verdict also included $6.3 million in compensatory damages.

The second case, also heard in Philadelphia, resulted in a punitive damage award of $75 million, and $3.5 million in compensatory damages. However, the punitive damage award in that case was ultimately reduced to $10.6 million.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo